Oral mucosal injury caused by mammalian target of rapamycin inhibitors: emerging perspectives on pathobiology and impact on clinical practice

Management of oral and gastrointestinal mucosal injury: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up

(2015) D. E. Peterson et al.   ANNALS OF ONCOLOGY

Mammalian Target of Rapamycin Inhibitor–Associated Stomatitis in Hematopoietic Stem Cell Transplantation Patients Receiving Sirolimus Prophylaxis for Graft-versus-Host Disease

(2015) Alessandro Villa et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Impact of haematologic deficiencies on recurrent aphthous ulceration: a meta-analysis

(2015) H. Chen et al.   BRITISH DENTAL JOURNAL

mTOR inhibitor-associated stomatitis (mIAS) in three patients with cancer treated with everolimus

(2015) Eleni-Marina Kalogirou et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2

(2014) H. S. Rugo et al.   ANNALS OF ONCOLOGY

Adverse Event Management of mTOR Inhibitors During Treatment of Hormone Receptor–Positive Advanced Breast Cancer: Considerations for Oncologists

(2014) Denise A. Yardley   Clinical Breast Cancer

Risk of mucocutaneous toxicities in patients with solid tumors treated with sorafenib: an updated systematic review and meta-analysis

(2014) Omar Abdel-Rahman et al.   Expert Review of Anticancer Therapy

Review of Preclinical Studies on Treatment of Mucositis and Associated Pain

(2014) C.T. Viet et al.   JOURNAL OF DENTAL RESEARCH

Mucosal Microbiome in Patients with Recurrent Aphthous Stomatitis

(2014) K. Hijazi et al.   JOURNAL OF DENTAL RESEARCH

TLR2,TLR4andCD86gene polymorphisms in recurrent aphthous stomatitis

(2014) Jumana Karasneh et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Pharmacotherapy for Adverse Events Reduces the Length of Hospital Stay in Patients Admitted to Otolaryngology Ward: A Single Arm Intervention Study

(2014) Akio Suzuki et al.   PLoS One

The oral microbiota of patients with recurrent aphthous stomatitis

(2014) Maria Bankvall et al.   Journal of Oral Microbiology

Immune responses of macrophages and dendritic cells regulated by mTOR signalling

(2013) Karl Katholnig et al.   BIOCHEMICAL SOCIETY TRANSACTIONS

Irinotecan disrupts tight junction proteins within the gut

(2013) Hannah R Wardill et al.   CANCER BIOLOGY & THERAPY

Mammalian target of rapamycin inhibitor-associated stomatitis

(2013) Christine B Boers-Doets et al.   Future Oncology

Inhibition of Caspases Protects Mice from Radiation-induced Oral Mucositis and Abolishes the Cleavage of RNA-binding Protein HuR

(2013) Sudha Talwar et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Oral mucosal injury caused by cancer therapies: current management and new frontiers in research

(2013) Siri B. Jensen et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients

(2013) ST Sonis et al.   ORAL DISEASES

Oral mucosal injury in oncology patients: perspectives on maturation of a field

(2013) DE Peterson et al.   ORAL DISEASES

A review of oral toxicity associated with mTOR inhibitor therapy in cancer patients

(2013) Fabiana Martins et al.   ORAL ONCOLOGY

Phase I study of vinblastine and sirolimus in pediatric patients with recurrent or refractory solid tumors

(2013) Daniel A. Morgenstern et al.   PEDIATRIC BLOOD & CANCER

Recurrent aphthous stomatitis: genetic aspects of etiology

(2013) Zuzanna Ślebioda et al.   Postepy Dermatologii i Alergologii

Emerging evidence on the pathobiology of mucositis

(2013) Noor Al-Dasooqi et al.   SUPPORTIVE CARE IN CANCER

Use of archived biopsy specimens to study gene expression in oral mucosa from chemotherapy-treated cancer patients

(2013) Jean-Luc C. Mougeot et al.   Oral Surgery Oral Medicine Oral Pathology Oral Radiology

Oral complications of cancer and cancer therapy

(2012) Joel B. Epstein et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Everolimus in the treatment of hormone receptor-positive breast cancer

(2012) Mariana Chavez-MacGregor et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

The MASCC/ISOO Mucositis Guidelines Update: introduction to the first set of articles

(2012) Rajesh V. Lalla   SUPPORTIVE CARE IN CANCER

Oral mucositis

(2011) Stephen T. Sonis   ANTI-CANCER DRUGS

Management of cancer therapy-induced oral mucositis

(2011) ANDREI BARASCH et al.   Dermatologic Therapy

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma

(2011) Camillo Porta et al.   EUROPEAN JOURNAL OF CANCER

Natural history, management and pharmacokinetics of Everolimus-induced-oral ulcers: Insights into compliance issues

(2011) Charles Ferté et al.   EUROPEAN JOURNAL OF CANCER

Incidence and risk factors of oral mucositis in paediatric and adolescent patients undergoing chemotherapy

(2011) Karis Kin Fong Cheng et al.   ORAL ONCOLOGY

Clinical presentation and management of mTOR inhibitor-associated stomatitis

(2011) Marcio Augusto de Oliveira et al.   ORAL ONCOLOGY

Oral complications of targeted cancer therapies: A narrative literature review

(2011) A.L. Watters et al.   ORAL ONCOLOGY

A Deletion Polymorphism in Glutathione-S-Transferase Mu (GSTM1) and/or Theta (GSTT1) Is Associated with an Increased Risk of Toxicity after Autologous Blood and Marrow Transplantation

(2010) Theresa Hahn et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Dysfunction of CD4+CD25high T regulatory cells in patients with recurrent aphthous stomatitis

(2010) Natalia Lewkowicz et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel

(2009) C. Sessa et al.   ANNALS OF ONCOLOGY

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis

(2009) Stephen T. Sonis   ORAL ONCOLOGY

The emerging safety profile of mTOR inhibitors, a novel class of anticancer agents

(2009) Kamalesh Sankhala et al.   Targeted Oncology

Patient-reported measurements of oral mucositis in head and neck cancer patients treated with radiotherapy with or without chemotherapy

(2008) Linda S. Elting et al.   CANCER